Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

4.32
Delayed Data
As of Apr 29
 -0.18 / -4.00%
Today’s Change
3.11
Today|||52-Week Range
8.19
-22.44%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close4.50
Today’s open4.53
Day’s range4.21 - 4.53
Volume61,398
Average volume (3 months)85,613
Market cap$114.3M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+74.42%
Earnings growth (this year)-14.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.22%
P/E ratioNM
Price/Sales28.93
Price/Book13.92

Competitors

 Today’s
change
Today’s
% change
LFVNLifeVantage Corp-0.06-0.66%
MTPMidatech Pharma PLC-0.17-3.60%
ISRIsoRay Inc0.000.00%
IBIOIbio Inc-0.01-1.41%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$4.8M
Annual profit (last year)-$8.1M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts

Partner Offers

Search for Jobs